Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::

陳範宇 (Fan-Yu Chen)

[Profile]

  • Education
    • MD, School of Medicine, China Medical University,
    • PhD, Institute of Emergency and Critical Care Medicine, National Yang-Ming University (ongoing),
  • Career and Experience
    Current Positions:
    • - Now, Attending Physician, Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital,
    • - Now, Lecturer, School of Medicine, National Yang Ming Chiao Tung University,
    Experiences:
    • - , Chief Resident, Department of Medicine, Taipei Veterans General Hospital,
    • - , Chief Resident, Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital,
    • - , Resident, Department of Medicine, Taipei Veterans General Hospital,
  • Medical Expertise
    1. Nephrology
    2. Dialysis
    3. Diabetic nephropathy
    4. Proteinuria
    5. Acute kidney injury
    6. Chronic kidney disease
  • License
    License of physician, Taiwan Board of Taiwan Society of Internal Medicine Board of Taiwan Society of Nephrology
  • Language Expertise
    Mandarin, Taiwanese, English

[Publications]

1. Chen FY, Chen CF, Tan AC, Chan CH, Chen FA, Liu WS, Chen TH, Ou SM, Li SY, Tsai MT, Chen YT*, Lin CC*. Long-term prognosis of vascular access in hemodialysis patients with systemic lupus erythematosus: a retrospective cohort study. Sci Rep. 2021 Jun 15;11(1):12519.

2. Yang CW, Chen FY, Chang FP, Ho Y, Wu BS, Yang AH, Tarng DC, Yang CY*. IgM mesangial deposition as a risk factor for relapses of adult-onset minimal change disease. BMC Nephrol. 2021 Jan 12;22(1):25.

3. Chen FY, Ho Yang, Tsai MT, Tarng DC. Combined Application of the Hepatitis C Virus Serologic Testing and the Nucleic Acid Amplification Testing Simultaneously for HCV Infection Isolation Strategy in Hemodialysis Units. C Acta Nephrologica. 2020 Sep 1;34:136-141.

4. Chen FY, Chen CH, Lin CC*. Hypertensive Crisis and Refractory Hypertension Caused by Atypical Hemolytic Uremic Syndrome and Effect of Eculizumab. Acta Cardiol Sin. 2018 Sep;34(5):446-449.

回到最上